Mark Ringhoffer Selected Research

Creatinine

2/2006

Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Ringhoffer Research Topics

Disease

15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023 - 07/2003
9	Leukemia 03/2011 - 09/2002
6	Neoplasms (Cancer) 01/2023 - 09/2002
3	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 08/2005
3	Multiple Myeloma 01/2021 - 02/2008
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2015 - 02/2008
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2007 - 09/2002
3	Melanoma (Melanoma, Malignant) 07/2005 - 09/2002
2	Infections 07/2023 - 01/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 12/2016
2	Lymphoma (Lymphomas) 10/2017 - 05/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2010 - 09/2009
2	Neoplasm Metastasis (Metastasis) 09/2009 - 09/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2004 - 09/2002
2	Breast Neoplasms (Breast Cancer) 08/2003 - 09/2002
1	Febrile Neutropenia 07/2023
1	Pathologic Complete Response 07/2023
1	Sepsis (Septicemia) 07/2023
1	Pneumonia (Pneumonitis) 07/2023
1	Thrombocytopenia (Thrombopenia) 07/2023
1	Bronchiolitis Obliterans Syndrome 10/2022
1	Meningitis 11/2010
1	Lymphatic Metastasis 01/2010
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2009
1	Cap Myopathy 09/2009
1	Residual Neoplasm 01/2007
1	Hypertension (High Blood Pressure) 02/2006
1	Proteinuria 02/2006
1	Anemia 02/2006
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2003
1	Carcinoma (Carcinomatosis) 09/2002

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 09/2009 - 09/2002
5	Hyaluronic Acid (Hyaluronan)IBA 02/2008 - 09/2002
4	Peptides (Polypeptides)IBA 07/2010 - 08/2005
2	midostaurinIBA 01/2022 - 01/2019
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2007 - 08/2005
2	Messenger RNA (mRNA)IBA 02/2004 - 09/2002
1	AnthracyclinesIBA 09/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2023
1	Gemtuzumab (Mylotarg)FDA Link 07/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	KIR ReceptorsIBA 01/2023
1	HLA-G Antigens (HLA G)IBA 10/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	micaIBA 12/2016
1	Azacitidine (5 Azacytidine)FDA Link 04/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2014
1	Protein Subunit VaccinesIBA 07/2010
1	trofosfamideIBA 01/2010
1	Docetaxel (Taxotere)FDA Link 01/2010
1	AndrogensIBA 01/2010
1	Choline (Choline Chloride)IBA 01/2010
1	Complementary DNA (cDNA)IBA 09/2009
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	bcr-abl Fusion ProteinsIBA 06/2007
1	Granzymes (Granzyme)IBA 06/2007
1	Imatinib Mesylate (Gleevec)FDA Link 06/2007
1	CreatinineIBA 02/2006
1	VaccinesIBA 08/2005
1	EnzymesIBA 08/2005
1	EpitopesIBA 08/2005
1	HLA-DR Antigens (HLA-DR)IBA 07/2005
1	Myeloblastin (Proteinase 3)IBA 07/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2004
1	Combined VaccinesIBA 02/2004
1	Immunoglobulin G (IgG)IBA 08/2003
1	AntibodiesIBA 08/2003
1	AcidsIBA 09/2002

Therapy/Procedure

10	Stem Cell Transplantation 01/2021 - 07/2003
8	Immunotherapy 07/2010 - 09/2002
7	Therapeutics 09/2023 - 09/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2003
4	Hematopoietic Stem Cell Transplantation 10/2022 - 11/2010
1	Cell Transplantation 01/2022
1	Consolidation Chemotherapy 01/2018
1	Salvage Therapy 04/2015
1	Radiotherapy 05/2013